Autism Identification Rates Rise to 1 in 31 U.S. Children, CDC Reports

Autism Identification Rates Increase to 1 in 31 U.S. Children

The Centers for Disease Control and Prevention (CDC) reports that autism identification among 8-year-olds in the U.S. has risen to 1 in 31 (3.2%) in 2022, up from 1 in 36 in 2020. The findings, published in the CDC's latest surveillance report, highlight significant shifts in recognition patterns, particularly among minority groups.

Reduced Disparities in Recognition

One notable change is improved identification of autism in Black, Hispanic, and Asian children. The CDC's data shows narrowing gaps in diagnosis rates, likely due to expanded screening programs like the CDC's Learn the Signs Act Early initiative and updated diagnostic criteria in the DSM-5 that better capture diverse presentations. However, these gains reflect overdue corrections to historical underdiagnosis in marginalized communities.

has risen to 1 in 31 (3.2%) in 2022, up from 1 in 36 in 2020.

Persistent Recognition Gaps

The report reveals ongoing disparities: boys are 3.4 times more likely to receive an autism identification than girls, a ratio unchanged for decades. Research suggests this reflects diagnostic bias in screening tools rather than biological prevalence. Geographic variability is also stark, with rates ranging from 9.7 to 53.1 per 1,000 children across regions—differences largely attributed to variations in service access and diagnostic practices rather than true population differences.

Why Identification Rates Are Rising

Experts attribute the increase primarily to:

• Expanded diagnostic criteria (DSM-5 updates)
• Increased early screening mandates
• Reduced racial bias in referrals (JAMA Pediatrics 2023)

As the Johns Hopkins Bloomberg School of Public Health notes, these administrative changes account for most observed increases, though some environmental contributors remain under study.

Data Limitations

The CDC's findings come from 11 monitoring sites, not a national sample, meaning local rates may vary. While the data robustly tracks identification trends, it cannot assess autism's actual population frequency or causes. The scientific consensus continues to reject any vaccine link, as affirmed by the National Academy of Medicine.